Mark Guerin - Aug 2, 2023 Form 4 Insider Report for Onconova Therapeutics, Inc. (ONTX)

Role
CFO AND COO
Signature
/s/ Mark Guerin
Stock symbol
ONTX
Transactions as of
Aug 2, 2023
Transactions value $
-$1,450
Form type
4
Date filed
8/4/2023, 04:45 PM
Previous filing
Jun 13, 2023
Next filing
Feb 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ONTX Common Stock Options Exercise +4.75K +21.48% 26.9K Aug 2, 2023 Direct F1
transaction ONTX Common Stock Tax liability -$1.45K -1.42K -5.29% $1.02 25.4K Aug 3, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONTX Restricted Stock Units Options Exercise $0 -4.75K -50% $0.00 4.75K Aug 2, 2023 Common Stock 4.75K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On August 2, 2021 the reporting person was granted 14,250 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.